Annalise.ai vs Lunit Compared on FDA Clearances for Chest X-Ray and Mammography
Annalise.ai holds eight FDA clearances, all chest X-ray and head CT triage. Lunit holds six, five of them mammography and tomosynthesis. The two overlap only on chest X-ray triage, where the counts are four to one. Who each one fits, and what neither does.
By the Radiological.ai team
November 2026 · 6 min read
Worklist
Structured report
DraftRun the assistant to draft this report for review.
Decision support. The radiologist reviews and signs every study.
Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional judgment.
The short answer: Annalise.ai and Lunit are rarely competing for the same study. Annalise.ai's eight FDA 510(k) clearances are all triage products, four on chest X-ray and four on head CT. Lunit's six US clearances are five for mammography and tomosynthesis and one chest X-ray triage product from 2021. If your reading list is mostly chest films and emergency head CT, Annalise.ai has the deeper US record. If your volume is breast screening, Lunit does. The overlap is a single product category, chest X-ray triage, and there Annalise.ai holds four clearances to Lunit's one. Neither company sells a tool that drafts your routine report.
Clearance lists grow several times a year. The counts here come from the FDA 510(k) database as queried on November 19, 2026, so confirm the current list with each vendor before you build a shortlist around it.
Annalise.ai vs Lunit at a glance
Nearly every comparison of these two reads like a feature chart. The FDA record is a better starting point because it is public, dated and specific to a product and an intended use.
| Annalise.ai | Lunit | |
|---|---|---|
| FDA 510(k) clearances on record | 8 | 6 |
| Product codes | QFM (chest X-ray triage) and QAS (head CT triage) | QDQ (mammography and tomosynthesis detection) and QFM (chest X-ray triage) |
| Chest X-ray | Four QFM records, from February 2022 to April 2025 | One QFM record, INSIGHT CXR Triage (K211733, November 2021) |
| Head CT | Four QAS records, all 2023 | None on record |
| Mammography and tomosynthesis | None on record | Five QDQ records: INSIGHT MMG (K211678, K260320) and INSIGHT DBT (K231470, K242652, K253796) |
| Newest clearance | April 23, 2025, Annalise Enterprise (K250831) | April 23, 2026, INSIGHT MMG v1.1.10 (K260320) |
| Where the product stops | Triage and notification | Detection support on breast imaging, triage on chest X-ray |
| Published pricing | No | No |
Where Annalise.ai is stronger
Annalise.ai's whole US record sits in two product codes, and both are about getting the right study in front of a radiologist sooner. The chest X-ray records start with CXR Triage Pneumothorax in February 2022 and run through Annalise Enterprise (K250831) in April 2025. The head CT records are the CTB Triage family (K223240, K231094, K231384 and K231767), all cleared in 2023.
That makes it a coherent buy for an emergency department or a hospital group where the problem is a long queue of chest films and head CTs with the occasional urgent finding buried inside. For pricing and what a quote should itemize, see Annalise.ai pricing from 8 FDA records.
Where Lunit is stronger
Lunit's record is a breast imaging record. Five of its six clearances are INSIGHT MMG for mammography and INSIGHT DBT for digital breast tomosynthesis, and the newest, K260320, was cleared in April 2026. A screening program or breast center has no equivalent product in the Annalise.ai catalogue, because Annalise.ai holds no breast clearance at all.
Lunit also sits in a wider breast stack. Lunit acquired Volpara, and the density and risk side of that is covered in Volpara alternatives for breast density, risk and tracking. If you buy for breast imaging, the comparison that matters is Lunit against other mammography detection vendors, not against Annalise.ai, and our Lunit alternatives page is the better starting point.
The one place they overlap: chest X-ray triage
Both vendors hold QFM clearances, which is the product code for radiological computer-aided triage and notification software on chest X-ray. Annalise.ai has four, Lunit has one (INSIGHT CXR Triage, K211733). A count of clearances is not a verdict on accuracy, and we do not publish accuracy figures for any vendor here. What the count does tell you is how much of the product's regulatory work has gone into this study type. For Lunit, chest X-ray is a side product. For Annalise.ai, it is the core.
Ask each vendor for the exact list of findings covered by the clearance you would be buying, because the cleared list is narrower than what either company markets outside the US. Then check the intended use statement in the 510(k) summary itself, which the FDA 510(k) database publishes for every record.
Annalise.ai vs Lunit for different buyers
| Your situation | Better fit | Why |
|---|---|---|
| Emergency department, chest X-ray and head CT queue | Annalise.ai | Eight triage clearances on exactly those two study types |
| Breast screening program | Lunit | Five mammography and tomosynthesis clearances, newest April 2026 |
| Mixed outpatient imaging group | Neither alone | Each covers a slice, and you would run two integrations for one worklist |
| Small group that needs the report written faster | Neither | Both stop at the flag, so drafting stays manual |
What neither vendor does
A flag changes the order in which a radiologist opens studies. It does not write the report. A radiologist who gets a pneumothorax flag still dictates or types the finding, applies the template and signs. Across a day of fifty or a hundred and fifty reads, that drafting step is where most of the minutes go, and it is untouched by both tools.
That is the gap Radiological.ai is built for. It flags suspected findings for your review, prioritizes the worklist so urgent studies surface first, and drafts the structured report in your template across X-ray, CT and MRI, then your radiologist edits and signs every study. It is decision support rather than a diagnosis, and we make no clearance claims for it. Plans are on the pricing page and priced per reading radiologist, so you can compare it to a per-module quote directly.
Questions to ask before you sign with either
- Which exact findings does the cleared product cover, and which are marketed but not cleared?
- Is the price per site, per study or per module, and what happens to the rate when your volume grows?
- Does the integration read from your PACS over DICOM and return the flag as a worklist priority, or does it need a second window? Our PACS integration page sets out what to expect.
- Who validates the product on your own images before go-live, and for how many weeks does it run in shadow mode?
- What does it cost to remove a module at renewal?
Annalise.ai vs Lunit: frequently asked questions
Is Annalise.ai better than Lunit?
Neither is better in general. Annalise.ai has eight FDA clearances in chest X-ray and head CT triage, and Lunit has five in mammography and tomosynthesis. Choose by the studies you read most. A hospital emergency department and a breast screening program would reasonably pick opposite vendors.
How many FDA clearances do Annalise.ai and Lunit have?
As of November 19, 2026, the FDA 510(k) database lists 8 clearances for Annalise.ai, the newest from April 2025, and 6 for Lunit, the newest from April 2026. Lunit's Volpara products are filed under a separate applicant and are not counted here.
Do Annalise.ai and Lunit compete on chest X-ray?
Yes, but only partly. Both hold chest X-ray triage clearances under product code QFM. Annalise.ai has four and Lunit one, from 2021. Lunit's other five records are all breast imaging, which Annalise.ai does not cover.
Does either tool write the radiology report?
No. Both flag or prioritize studies and leave the report to your reporting system. Radiological.ai drafts the structured report in your template after flagging, and the radiologist reviews and signs it.
Do Annalise.ai or Lunit publish their pricing?
Neither does. Both quote per deployment. Ask for every module itemized, the study volume the price assumes and the renewal terms. Our Annalise.ai vs Qure.ai comparison covers the same questions for the other main chest X-ray vendor.
See Radiological.ai read a study
The assistant flags suspected findings for review, prioritizes the worklist so urgent studies surface first, and drafts the structured report into your template. You review, edit and sign every study.